From RT.com…
A candidate vaccine that uses a novel platform and may be good enough to deal with existing and emerging variants of SARS-CoV-2 viruses, will reportedly be announced soon by researchers at the Walter Reed Army Institute in the US.
The unveiling may come “within weeks,” according to Dr. Kayvon Modjarrad, director of Walter Reed’s infectious diseases branch, who was interviewed by Defense One.
According to the military publication, the candidate vaccine may offer a single-shot, wide-scale immunity from diseases caused by human coronaviruses, including from future mutations.
